NCCN guidelines may not be best management of HPV+ patients after treatment #hncs16
Jessica M. Frakes, MD of Moffitt Cancer Center discusses why NCCN guidelines may not be best management of HPV+ patients after treatment at ASTRO Head and Neck Symposium 2016.
Author: ASTROHN2016
Added: 02/24/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2016 Category: Cancer & Oncology Source Type: podcasts
Uninsured and Medicaid patients more likely advanced tumors in head and neck cancer #hncs16
Thomas Churilla, MD of Fox Chase Cancer Center discusses Uninsured and Medicaid patients with head and neck cancer more likely to present with advanced tumors, experience cancer specific mortality at ...
Author: ASTROHN2016
Added: 02/24/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 24, 2016 Category: Cancer & Oncology Source Type: podcasts
VEGFR in well-differentiated thyroid cancer
Dr. Keith C. Bible, MD or the Mayo Clinic discusses how important a target is VEGFR in well-differentiated thyroid cancer at ASTRO Head and Neck Symposium
Author: ASTROHN2016
Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts
Standard of care for RAI refractory well-differentiated thyroid cancer
Dr. Keith C. Bible, MD or the Mayo Clinic discusses standard of care for RAI refractory well-differentiated thyroid cancer at ASTRO Head and Neck Symposium
Author: ASTROHN2016
Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts
Tricks to help minimize adverse events with sorafenib in thyroid cancer #hncs16
Dr. Keith C. Bible, MD or the Mayo Clinic discusses tricks to help minimize and prevent adverse events with sorafenib and other TKIs in thyroid cancer at ASTRO Head and Neck Symposium
Author: ASTROHN2016
Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts
De-intensified Chemoradiotherapy affect HPV-associated cancers #hncs16 @ASTRO_org
Dr. Bhishamjit S. Chera, MD of the University of North Carolina Hospitals, Chapel Hill, North Carolina discusses his study at ASTRO Head and Neck Conference 2016
Purpose
To perform a prospective, ...
Author: ASTROHN2016
Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts
Subgroup analysis of phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD, PhD, from National Cancer Center Hospital East, Kashi...
Author: EMJ
Added: 02/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 20, 2016 Category: Cancer & Oncology Source Type: podcasts
The role of radiation therapy in oral cavity cancers #hncs16 @ASTRO_org
Dr. David Adelstein, MD of Cleveland Clinic discusses what is the role of radiation therapy in oral cavity cancers at the ASTRO Head and Neck Symposium 2016.
Author: ASTROHN2016
Added: 02/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Groups that are most at risk for Oral Cavity Cancers #hncs16 @ASTRO_org
Dr. David Adelstein, MD of Cleveland Clinic discusses which groups are most susceptible to oral cavity cancers at the ASTRO Head and Neck Symposium 2016 in Scottsdale, Arizona.
Author: ASTROHN2016
Added: 02/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Karam_Study Results_Survival Outcomes with Concurrent Chemoradiation for Locally Advanced Elderly Head and Neck Cancer Patients #hncs16 @ASTRO_org
4,042 patients were included: 2,538 (63%) received CRT. Median follow-up was 19
months. Unadjusted median OS was longer with the addition of CRT (p<0.001). OS was superior
with CRT on MVA (HR, 0....
Author: ASTROHN2016
Added: 02/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Key Points: Survival Outcomes with Concurrent Chemoradiation for Locally Advanced Elderly Head and Neck Cancer Patients #hncs16 @ASTRO_org
The NCDB is a joint project of the Commission on Cancer of the American College of
Surgeons and the American Cancer Society. It is a hospital-based registry that represents 70% of
all cancer c...
Author: ASTROHN2016
Added: 02/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Overview: Survival Outcomes with Concurrent Chemoradiation for Locally Advanced Elderly Head and Neck Cancer Patients Using the National Cancer Data Base
Approximately 45,000 new head and neck squamous cell carcinomas (HNSCC) are diagnosed
annually in the United States, with at least one-quarter occurring in patients >70 years of age.1,2
Tailoring...
Author: ASTROHN2016
Added: 02/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 19, 2016 Category: Cancer & Oncology Source Type: podcasts
Strategies for immunotherapy in head and neck cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Dr Tanguy Seiwert from The University of Chicago Medicine, Chicago, IL, ...
Author: PatientPowerEU
Added: 02/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2016 Category: Cancer & Oncology Source Type: podcasts
Therapeutic advances in immune checkpoint inhibitors for head and neck cancers
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from The University of Chicago Medicine, Chicago, IL...
Author: EMJ
Added: 02/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2016 Category: Cancer & Oncology Source Type: podcasts
Incidence of Suicide in Patients With Head and Neck Cancer (JAMA Otolaryngology —Head & Neck Surgery)
Interview with Richard Chan Woo Park, MD, author of Incidence of Suicide in Patients With Head and Neck Cancer (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 12, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
